Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2003
06/05/2003US20030104399 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of body weight and aging disorders
06/05/2003US20030104396 Composition and method for optimized hybridization using modified solutions
06/05/2003US20030104395 Enzymes for use in the reduction of aberrant nucleotide sequences during polymerase chain reaction
06/05/2003US20030104394 Apparatus for monitoring and classification of nucleoetide sequence expression
06/05/2003US20030104393 Detection and evalution of damages caused hypoxia, hypoglycemia, stroke, motor, epileptic, diabetic, infections, psychosis, headache and cell proliferative diseases
06/05/2003US20030104392 Screening and propagation of swine genomes with heat resistant phenotypes
06/05/2003US20030104390 Solid support for use in the detection of plant parasites
06/05/2003US20030104387 Mutation detection on RNA polmerase beta subunit gene having rifampin resistance
06/05/2003US20030104386 Methods for the specific detection of redox-active tags and the use thereof for capillary gel electrophoresis and DNA sequencing
06/05/2003US20030104385 Enzymatic polypeptide for use in the diagnosis and treatment of psychological disorders
06/05/2003US20030104384 Trangenic cell library for monitoring phenotypic adjustments associated with gene transfer
06/05/2003US20030104383 Nucleic acid, nucleic acid for detecting chlorinated ethylene-decomposing bacteria, probe, method of detecting chlorinated ethylene-decomposing bacteria, and method of decomposing chlorinated ethylene or ethane
06/05/2003US20030104382 Examining the DNA sample for the presence or absence of a T1640C mutation
06/05/2003US20030104381 Nucleotide sequences coding polypeptide for use in treatment of heart, cancer and skin disorders
06/05/2003US20030104379 HY2 family of bilin reductases
06/05/2003US20030104378 Ribozyme kit for use in detection of preferential nucleotide sequences in sample
06/05/2003US20030104377 Tenascin-C nucleic acid ligands
06/05/2003US20030104376 Assay
06/05/2003US20030104375 Light-driven energy generation using proteorhodopsin
06/05/2003US20030104373 Novel oligonucleotide primers for phosphotidyl inositol in Bacillus cereus and a method for the detection of Bacillus cereus
06/05/2003US20030104372 Allele specific primer extension
06/05/2003US20030104371 Methods of evaluating transplant rejection
06/05/2003US20030104369 Method for generation of longer cDNA fragments from sage tags for gene identification
06/05/2003US20030104368 Monitoring protein binding pattern in sample; for use in evaluation and detection of gene expression controls
06/05/2003US20030104367 Method for detecting transcription templates
06/05/2003US20030104366 Polypeptides for use in the diagnosis and prevention of tumors; antiproliferative agents
06/05/2003US20030104365 Polypeptide for use in the diagnosis and treatment of alzheimer's disease
06/05/2003US20030104363 Use of magnetic besds to separate preferential nucleotide sequences
06/05/2003US20030104361 Nucleotide sequences probe for use as tool in detection of preferential particles in sample; for use in diagnosis of disease, genetic monitoring, forensics and analysis of nucleic acid mixtures
06/05/2003US20030104360 Synthetic receptors, libraries and uses thereof
06/05/2003US20030104356 Compounds and methods for treating and screening viral reactivation
06/05/2003US20030104355 Adapter-directed display systems
06/05/2003US20030104354 Method and device for the rapid clinical diagnosis of human cytomegalovirus (hCMV) infection in biological samples
06/05/2003US20030104119 Microbiosensor
06/05/2003US20030104045 Novel therapeutic binding molecule complexes
06/05/2003US20030104011 Inactivated reverse transcriptase.
06/05/2003US20030104009 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
06/05/2003US20030103963 Complementary determining regions capable binding to the same antigen as the monoclonal antibody 8H9; inhibit competitive binding; isolated scFv of monoclonal antibody 8H9, antigen, antitumor agents
06/05/2003US20030103949 Cell proliferation
06/05/2003US20030103938 Pharmaceutical compositions for preventing or treating Th1 and Th2 cell related diseases by modulating the Th1/Th2 ratio
06/05/2003US20030103902 Membrane transportable fluorescent substrates
06/05/2003US20030103898 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
06/05/2003US20030102510 Molecular detection chip including mosfet , molecular detection device employing the chip, and molecular detection method using the device
06/05/2003US20030102213 Biosensor
06/05/2003DE19758531C2 Analyte detection device for self-monitoring of blood glucose by diabetics
06/05/2003CA2812024A1 Methods for ligand discovery
06/05/2003CA2676478A1 Assaying apparatus, kit, and method for lipids and associated enzymes
06/05/2003CA2486924A1 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization
06/05/2003CA2469772A1 Methods for the identification of inhibitors of alpha-aminoadipate reductase and homocitrate synthase as antibiotics
06/05/2003CA2468874A1 Method to isolate genes involved in aging
06/05/2003CA2468838A1 Methods of using improved polymerases
06/05/2003CA2468411A1 Method for detecting hybridization events in nucleic acids
06/05/2003CA2468409A1 Method for analyzing translation-controlled gene expression
06/05/2003CA2468408A1 Human cdnas and proteins and uses thereof
06/05/2003CA2468353A1 A novel homeobox gene
06/05/2003CA2468316A1 Novel compositions and methods for cancer
06/05/2003CA2468312A1 Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness
06/05/2003CA2468245A1 Magneto-optical bio-discs and systems including related methods
06/05/2003CA2468240A1 Muscle transcription factors
06/05/2003CA2468161A1 Polypeptide quantitation
06/05/2003CA2468020A1 Osteopontin-related compositions and methods
06/05/2003CA2467892A1 Methods and compositions for derepression of iap-inhibited caspase
06/05/2003CA2467854A1 Sir2 products and activities
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/05/2003CA2466821A1 Digital assay
06/05/2003CA2466615A1 Detection and identification of enteric bacteria
06/05/2003CA2466596A1 Cyp46 genotype determination for risk and treatment evaluation of alzheimer's disease
06/05/2003CA2464839A1 Artificial genes for use as controls in gene expression analysis systems
06/05/2003CA2464094A1 Methods for ligand discovery
06/04/2003EP1316909A1 In silico screening method for inhibitors of glutamyl-tRNA reductase
06/04/2003EP1316802A2 An ananalyzing method of a blood coagulation reaction
06/04/2003EP1316619A1 Method for detecting cells with numerical chromosomal abnormalities
06/04/2003EP1316618A2 Nucleic acids for marking objects
06/04/2003EP1316616A1 Method for producing linear DNA fragments for the in vitro expression of proteins
06/04/2003EP1316609A1 Acetoacetyl-CoA thiolase and its use for identifying new fungicidal substances
06/04/2003EP1316607A1 Pseudo-cyclic oligonucleobases for inhibiting tumor growth
06/04/2003EP1316606A1 Method for separation and purification of nucleic acid and unit for separation and purification of nucleic acid
06/04/2003EP1316560A1 Novel human cancer/testis antigen and gene thereof
06/04/2003EP1316049A2 Analysis of data from liquid chromatographic separation of dna
06/04/2003EP1316023A2 Specific identifiers of amino-acid and base sequences
06/04/2003EP1315974A2 Split-ubiquitin based reporter systems and methods of their use
06/04/2003EP1315972A2 Method for detecting the activity of active ingredients
06/04/2003EP1315970A1 Nucleic acid sequences and proteins involved in cellular senescence
06/04/2003EP1315969A2 Cell assays
06/04/2003EP1315967A2 Immunosensor
06/04/2003EP1315966A1 Method of monitoring the effect of cathepsin s inhibitors
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315963A1 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
06/04/2003EP1315958A2 Assay methods
06/04/2003EP1315957A2 Method of identification and quantification of biological molecules and apparatus therefor
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315839A1 Amplification of hiv-1 sequences for detection of sequences associated with drug-resistance mutations
06/04/2003EP1315838A2 Method of establishing resistance profiles of tissues and cell lines
06/04/2003EP1315837A2 5-hydroxytryptamine receptor gene polymorphisms and response to treatment
06/04/2003EP1315836A2 Bioluminescent methods for direct visual detection of environmental compounds
06/04/2003EP1315835A2 Directed differentiation of embryonic cells
06/04/2003EP1315834A2 Artificial marking using synthetic dna
06/04/2003EP1315833A2 Multiply-primed amplification of nucleic acid sequences
06/04/2003EP1315832A2 Method for measurement of the activity of no-synthase
06/04/2003EP1315831A2 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents